Key result
Anthracycline therapy abstract lacks quantitative results on late cardiac strain in childhood cancer survivors.
Why the study?
Anthracycline-based therapies cause cancer therapy-related cardiac dysfunction in childhood cancer survivors, motivating evaluation of CMR feature tracking strain as a marker of subclinical dysfunction.
Does anthracycline-based therapy cause subclinical changes in cardiac strain evaluated by CMR-FT in childhood cancer survivors?
Cross-Sectional (n=196)
Does anthracycline-based therapy cause subclinical changes in cardiac strain evaluated by CMR-FT in childhood cancer survivors?
Cross-sectional study reveals subclinical cardiac strain alterations in childhood cancer survivors, highlighting CMR feature tracking for early cardiotoxicity detection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mojica‐Pisciotti et al. (2026) conducted a cross-sectional in Childhood cancer survivors (n=196). Anthracycline-based therapy vs. Age- and sex-matched controls was evaluated on Cardiac strain evaluated with cardiovascular magnetic resonance feature tracking (CMR-FT).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: